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ABSTRACT	
	
Objective.	HIV	remains	a	highly	stigmatized	illness	in	the	United	States,	and	many	people	living	with	HIV	(PLWH)	in	treatment	must	make	difficult	decisions	about	disclosing	their	HIV	status	to	sexual	partners.	Because	knowledge	of	a	sexual	partner’s	HIV	serostatus	can	facilitate	preventative	health	measures,	an	understanding	of	the	factors	that	affect	disclosure	decision-making	and	subsequent	condom	use	behavior	may	help	to	design	effective	interventions.	Alcohol	and	illicit	drug	use	are	prevalent	in	PLWH	engaged	in	medical	care,	and	could	impact	these	decision-making	processes.	We	sought	to	examine	the	acute	relationships	between	substance	use,	HIV	serostatus	disclosure,	and	condom	use	on	an	event-level	basis.	
Method.	Men	and	women	living	with	HIV	were	recruited	from	community	services	and	infectious	disease	clinics	in	a	southeastern	US	city.	Participants	reported	on	demographic	information	and	psychosocial	and	physical	health	variables	via	audio-computer	assisted	self-interviews	(ACASI)	at	study	entry,	and	completed	a	urine	drug	toxicity	screen.	Participants	also	reported	daily	sexual	behavior	for	28	consecutive	days	via	daily	interactive	text	message	prompts.	Daily	reports	specified	whether	anal	or	vaginal	intercourse	occurred,	whether	with	a	first-time	sexual	partner,	whether	the	participant	disclosed	their	HIV-positive	serostatus,	whether	the	participant	ascertained	their	partner’s	HIV	status,	whether	the	participant	and/or	their	partner	used	substances	prior	to	intercourse	(including	alcohol	or	other	drugs),	and	whether	a	condom	was	used.	We	employed	multi-level	modeling	to	evaluate	the	event-level	associations	between	substance	use,	HIV	serostatus	
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disclosure,	and	condom	use	in	all	first-time	sexual	encounters	involving	sexual	partners	whose	HIV	serostatus	was	HIV-negative	or	unknown.	
Results.	Out	of	a	larger	study	sample,	251	participants	(85%	male,	92%	African	American)	reported	engaging	in	anal	or	vaginal	intercourse	with	a	first-time	sexual	partner	whose	HIV	status	was	negative	or	unknown,	with	a	total	of	529	first-time	partners	reported	during	the	study	period	(mean=2.11	partners).	At	the	event	level,	substance	use	at	the	time	of	sex	did	not	predict	odds	of	condom	use	among	inconsistent	condom	users	(p>0.05);	however,	on	average,	heavier	alcohol	users	tended	to	be	those	most	likely	to	engage	in	condomless	sex	(p=0.01).	Participants	disclosed	their	HIV	serostatus	to	only	32%	of	first-time	non-HIV-positive	sexual	partners.	Event-level	substance	use	negatively	predicted	HIV	serostatus	disclosure	across	the	28-day	study	period	(odds	ratio=0.46;	p=0.04).	Disclosure	was	more	frequent	among	consistent	condom	users	than	those	who	consistently	engaged	in	condomless	sex	(p<0.01),	yet	disclosure	was	not	related	to	increased	condom	use	among	inconsistent	condom	users	at	the	event	level	(p>0.05).	
Conclusions.	This	study	demonstrates	that	substance	use	just	prior	to	intercourse	is	associated	with	decreased	HIV	serostatus	disclosure	in	PLWH.	This	is	the	first	study	to	use	multilevel	modeling	techniques	to	examine	the	relationship	between	substance	use	and	HIV	serostatus	disclosure	at	the	daily	event	level.	Substance	using	PLWH	may	benefit	from	interventions	designed	to	moderate	substance	use	or	enhance	behavior	skills	for	reducing	HIV	transmission	risk	when	using	substances.
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	 	 INTRODUCTION	
Sexual	Transmission	of	HIV/AIDS	in	the	United	States	With	over	1.2	million	people	currently	living	with	HIV	(PLWH)	in	the	United	States,	HIV	continues	to	contribute	to	major	health	disparities	(Center	for	Disease	Control	and	Prevention,	2016)	.	Over	90%	of	new	infections	in	2016	were	attributable	to	sexual	contact,	with	marked	disparities	in	incidence	by	race,	income,	gender,	and	sexual	identity.	Men	who	have	sex	with	men	(MSM)	accounted	for	a	disproportionate	two-thirds	of	new	diagnoses	in	2016,	and	HIV	incidence	continues	to	rise	in	Black	and	Latino	MSM		(Center	for	Disease	Control	and	Prevention,	2017)	.	Despite	significant	advances	in	available	HIV	treatment	and	prevention	options	(e.g.,	highly	active	antiretroviral	therapy	(HAART)	and	Pre-Exposure	Prophylaxis	(PrEP)),	efforts	have	failed	to	curb	sexual	transmission	of	HIV.	Thus,	efforts	to	understand	and	modify	health-related	behaviors	remain	crucial	for	HIV	prevention.	
HIV	Partner	Disclosure	Disclosure	of	positive	HIV	serostatus	enables	sexual	partners	of	PLWH	to	make	informed	choices	regarding	acceptable	levels	of	HIV	transmission	risk.	As	such,	sexual	partner	disclosure	has	been	targeted	as	an	important	component	of	prevention	interventions	in	PLWH		(Chiasson,	Shaw,	Humberstone,	Hirshfield,	&	Hartel,	2009;	Conserve,	Groves,	&	Maman,	2015;	Kalichman	et	al.,	2001;	Serovich,	Laschober,	Brown,	&	Kimberly,	2017)	.	Such	interventions	propose	that	if	non-HIV-
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positive	sex	partners	are	informed	of	their	acute	risk	of	HIV	transmission,	they	will	be	more	motivated	to	implement	HIV	prevention	strategies	such	as	condom	use.	Decisions	concerning	whether	to	disclose	positive	HIV	status	are	complicated	by	the	highly	charged	social	and	legal	context	in	which	they	occur		(Parsons,	VanOra,	Missildine,	Purcell,	&	Gómez,	2004;	Parsons,	Schrimshaw,	Bimbi	et	al.,	2005)	.	Given	that	disclosure	affords	sex	partners	of	PLWH	the	opportunity	to	make	more	informed	decisions	concerning	their	acceptable	levels	of	HIV	risk,	some	public	health	officials	have	argued	that	HIV	disclosure	is	a	moral	imperative,	with	PLWH	possessing	a	“duty	to	warn”		(Marks	&	Crepaz,	2001;	Stein	et	al.,	1998)	.	In	many	US	states,	this	stance	has	been	codified	into	law;	approximately	half	of	states	currently	impose	criminal	penalties	for	non-disclosure	of	positive	HIV	status	to	sexual	partners		(Lehman	et	al.,	2014)	.	Research	indicates	that	many	PLWH	believe	themselves	to	be	personally	responsible	for	preventing	potential	HIV	transmission	to	their	sexual	partners	(Serovich	&	Mosack,	2003;	Wolitski,	Bailey,	O'Leary,	Gómez,	&	Parsons,	2003)	.	Yet	despite	legal	repercussions	and	public	health	strategies	designed	to	increase	HIV	disclosure	in	PLWH,	non-disclosure	of	HIV	status	to	sexual	partners	occurs	frequently.	One	probability	sample	of	PLWH	in	medical	care	found	that	42%	of	MSM,	19%	of	heterosexual	men,	and	17%	of	heterosexual	women	living	with	HIV	reported	having	sex	without	disclosing		(Ciccarone	et	al.,	2003;	Serovich	&	Mosack,	2003)	.	Reasons	for	non-disclosure	of	HIV	status	vary.	HIV	remains	a	highly	stigmatized	illness	in	the	United	States,	and	the	large	majority	of	PLWH	engaged	in	care	endorse	internalized	negative	attitudes	regarding	HIV		(Baugher	et	al.,	2017)	.	
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The	competing	consequences	theory	of	disclosure	suggests	that	PLWH	tend	to	disclose	their	HIV	status	in	instances	in	which	they	appraise	the	benefits	of	disclosure	to	outweigh	the	perceived	costs		(Serovich,	2001)	.	Thus,	PLWH	must	often	weigh	the	potential	HIV	prevention	benefits	against	a	number	of	potential	costs.	Anticipated	negative	partner	reactions	and	fear	of	secondary	disclosure	are	each	associated	with	decreased	likelihood	of	disclosure	to	sexual	partners		(Baugher	et	al.,	2017;	Bird,	Eversman,	&	Voisin,	2017;	Galletly	&	Dickson-Gomez,	2009;	Przybyla	et	al.,	2013;	Smit	et	al.,	2012)	.	High	rates	of	intimate	partner	violence	following	disclosure	present	serious	threats	for	both	MSM	and	women	living	with	HIV,	and	risk	of	victimization	is	especially	high	among	people	who	report	greatest	levels	of	substance	use		(Brown,	Serovich,	&	Kimberly,	2016;	Gielen,	McDonnell,	Burke,	&	O'campo,	2000)	.	Thus,	low	self-efficacy	about	communicating	HIV	status	to	partners	as	well	as	anticipated	negative	consequences	of	disclosure	often	hinder	disclosure	efforts		(Bird	&	Voisin,	2013;	Crawford,	Rodden,	Kippax,	&	Van	de	Ven,	2001;	Serovich	&	Mosack,	2003)	.	In	the	face	of	these	significant	barriers,	many	PLWH	practice	selective	disclosure	to	sexual	partners,	disclosing	their	HIV-positive	status	to	some	but	not	others		(Bird	&	Voisin,	2013;	Parsons	et	al.,	2005;	Przybyla	et	al.,	2013)	.	Such	decisions	require	a	weighing	of	the	costs	and	benefits	associated	with	disclosing	to	a	specific	sexual	partner		(Serovich,	2001)	.	Perceptions	of	partner	trustworthiness	have	been	identified	as	one	important	determinant	of	such	decisions	to	disclose		(Bird	et	al.,	2017)	.	A	range	of	research	has	indicated	that	serostatus	disclosure	occurs	less	frequently	with	casual	as	opposed	to	with	regular	sex	partners,	perhaps	
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in	part	because	less	may	be	known	about	the	trustworthiness	of	sexual	partners	in	such	encounters		(Bird	&	Voisin,	2013;	Ciccarone	et	al.,	2003;	Perry	et	al.,	1994;	Przybyla	et	al.,	2013)	.	Additionally,	demand	characteristics	across	a	variety	of	casual	sex	contexts	may	further	pressure	individuals	to	engage	in	sex	with	little	prior	conversation		(Bird	et	al.,	2017;	Prestage	et	al.,	2001)	.	Thus,	sexual	encounters	between	PLWH	and	their	non-regular	sexual	partners	are	particularly	likely	to	involve	uninformed	decision-making	regarding	sexual	risk	reduction.	As	such,	these	encounters	pose	particularly	high	risk	for	HIV	transmission.	A	comprehensive	understanding	of	disclosure	decision-making	in	casual	or	first-time	sexual	encounters	is	therefore	valuable	for	informing	HIV	prevention	strategies.	One	important	factor	in	decisions	to	disclose	may	be	substance	use.	
Substance	Use	and	HIV	Transmission	Risk		 Use	of	alcohol	and	other	drugs	has	been	widely	studied	for	its	role	in	understanding	HIV	transmission	risk	behavior		(Bourne	&	Weatherburn,	2017;	Bryan,	Schmiege,	&	Magnan,	2012;	Scott-Sheldon	et	al.,	2013)	.	On	average,	people	who	engage	in	heavier	drug	and	alcohol	use	are	more	likely	to	have	condomless	anal	and	vaginal	sex,	to	engage	in	unprotected	sex	with	a	greater	number	of	partners,	and	to	acquire	HIV		(Cooper,	2002;	Koblin	et	al.,	2006a;	Reilly	&	Woo,	2001;	Weinhardt	&	Carey,	2000)	.	However,	the	extent	to	which	these	associations	are	causal	or	attributable	to	co-occurring	risk	factors	is	less	certain.	Person-level	studies,	or	those	that	measure	participants’	average	(global)	behavior,	cannot	observe	whether	behaviors	of	interest	co-occur	at	a	given	time	within	an	individual.	By	contrast,	event-level	research	has	helped	to	investigate	the	direct	relationship	
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between	these	behaviors	by	examining	whether	the	likelihood	of	condomless	sex	is	greater	in	sexual	events	where	substance	use	is	present.	While	many	such	studies	have	suggested	a	relationship	between	substance	use	and	risky	sexual	behavior,	not	all	event-level	studies	have	observed	this	substance	use-sexual	risk	link		(Bryan	et	al.,	2012;	Colfax	et	al.,	2004;	Koblin	et	al.,	2006a;	Vanable	et	al.,	2004;	Vosburgh,	Mansergh,	Sullivan,	&	Purcell,	2012)	.	Some	researchers	have	also	noted	that	an	event-level	relationship	between	substance	use	and	sexual	risk	behavior	does	not	by	itself	demonstrate	causation,	as	this	relationship	may	be	confounded	by	situational	characteristics	of	the	sexual	event		(Barta	et	al.,	2008)	.	Efforts	to	disentangle	this	relationship	have	observed	a	dose-related	relationship	of	alcohol	use	with	sexual	risk-taking	in	PLWH	and	in	young	non-positive	MSM,	suggesting	that	a	greater	number	of	drinks	prior	to	a	sexual	event	is	associated	with	an	increasing	likelihood	of	engaging	in	condomless	sex		(Barta	et	al.,	2008;	Kahler	et	al.,	2015)	.	Differences	in	personal	and	situational	factors	may	help	to	explain	the	mixed	relationships	between	substance	use	and	sexual	risk	behavior	across	event-level	studies.	While	one	event-level	study	found	that	young	MSM	were	more	likely	to	engage	in	condomless	anal	sex	with	serodiscordant	partners	on	drinking	days,	a	study	in	adolescent	women	found	no	relationship	between	alcohol	or	marijuana	use	and	condom	use		(Hensel,	Stupiansky,	Orr,	&	Fortenberry,	2011;	Kahler	et	al.,	2015)	.	Another	study	in	MSM	found	that	alcohol	use	had	no	effect	on	condom	use	with	primary	partners,	but	greatly	increased	risk	of	unprotected	sex	with	non-primary	
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sex	partners		(Vanable	et	al.,	2004)	.	Thus,	the	link	between	substance	use	and	sexual	risk	appears	to	be	moderated	by	a	number	of	factors.	The	link	between	substance	use	and	sexual	risk	behavior	is	also	likely	to	vary	across	drug	types.	Event-level	associations	appear	to	be	particularly	strong	in	the	cases	of	alcohol	use	and	methamphetamine	use,	and	have	also	demonstrated	increased	sexual	risk	taking	associated	with	marijuana	and	ecstasy/MDMA	use		(Bourne	&	Weatherburn,	2017;	Bryan	et	al.,	2012;	Card	et	al.,	2017;	Vosburgh	et	al.,	2012)	.	Event-level	research	regarding	other	types	of	drug	use	is	sparse,	although	global	and	situational	association	studies	tend	to	support	consistent	links	between	various	classes	of	drug	use	and	sexual	risk	taking,	including	stimulant	drug	use	(crystal	meth,	crack	&	other	cocaine),	club	drug	use	(methamphetamine,	MDMA,	ketamine,	GHB,	poppers),	and	use	of	intravenously	delivered	drugs	such	as	heroin		(Colfax	et	al.,	2004;	Khan	et	al.,	2013;	Mayer,	Colfax,	&	Guzman,	2006;	Mayer,	Skeer,	O'Cleirigh,	Goshe,	&	Safren,	2014;	Purcell,	Parsons,	Halkitis,	Mizuno,	&	Woods,	2001;	Thiede	et	al.,	2009)	.	Of	note,	these	global	associations	between	substance	use	and	sexual	risk	taking	have	been	observed	in	a	number	of	populations	at	highest	risk	for	acquiring	or	transmitting	HIV	in	the	US,	including	MSM	receiving	medical	treatment	for	HIV,	non-HIV-positive	MSM,	and	young	adult	men	and	women		(Bruce,	Kahana,	Harper,	Fernandez,	&	ATN,	2013;	Jones-Webb,	Smolenski,	Brady,	Wilkerson,	&	Rosser,	2013;	Mayer	et	al.,	2014;	Patrick,	O’Malley,	Johnston,	Terry-McElrath,	&	Schulenberg,	2012;	Reilly	&	Woo,	2001;	Scott-Sheldon	et	al.,	2013)	.		
Why	does	substance	use	increase	sexual	risk	behavior?	
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Physiological	effects	of	substance	use	on	sexual	risk	behavior		 Researchers	have	identified	multiple	pathways	by	which	substance	use	may	confer	increased	risk	of	sexual	transmission	of	HIV.	One	such	pathway	is	the	direct	physiological	effect	of	a	substance	such	as	alcohol	on	executive	function	and	decision-making	processes		(Day,	Kahler,	Ahern,	&	Clark,	2015;	Simons,	Maisto,	Wray,	&	Emery,	2016)	.	Traditional	sociocognitive	frameworks	for	understanding	sexual	risk	behavior	hold	that	people	make	decisions	based	on	a	number	of	key	appraisals.	For	instance,	the	Theory	of	Planned	Behavior	holds	that	people	make	behavioral	decisions	based	on	their	attitudes	regarding	a	given	behavior	(e.g.,	“Do	I	consider	using	condoms	to	be	important?	Unpleasant?”),	perceived	social	norms	regarding	the	behavior	(e.g.,	“Do	others	like	me	usually	use	condoms?”),	and	the	perceived	degree	of	control	they	feel	they	have	over	performing	the	behavior	(e.g.,	“Can	I	successfully	negotiate	condom	use	with	my	sexual	partner?”)		(Ajzen,	2002;	Albarracin,	Johnson,	Fishbein,	&	Muellerleile,	2001)	.	Yet	while	these	cognitive	appraisals	have	been	shown	to	predict	behavioral	intentions	and	subsequent	HIV	transmission	risk	behaviors,	such	assessments	of	risks	and	benefits	are	unlikely	to	remain	stable	in	the	“heat	of	the	moment”	when	substance	use	is	involved		(Davis	et	al.,	2016)	.		 Alcohol	myopia	theory	has	suggested	one	explanation	for	alcohol’s	interference	with	typical	appraisal-based	behavior	patterns.	According	to	alcohol	myopia	theory,	the	acute	pharmacological	effects	of	alcohol	produce	impairment	in	executive	functioning,	therefore	altering	the	cognitive	processes	underlying	behavioral	decision-making		(Field,	Wiers,	Christiansen,	Fillmore,	&	Verster,	2010;	
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Steele	&	Josephs,	1990)	.	The	theory	holds	that	people	under	the	acute	influence	of	alcohol	increasingly	attend	to	immediate,	impelling	cues	(such	as	sexual	arousal),	and	reduce	attention	to	more	distant	or	abstract	inhibiting	cues	(such	as	the	risk	of	sexually	transmitted	infections	(STIs))		(Steele	&	Josephs,	1990;	Taylor	&	Leonard,	1983)	.	This	narrowed	attentional	focus,	in	conjunction	with	increases	in	subjective	sexual	arousal,	is	thought	to	engender	increased	willingness	to	engage	in	risky	sexual	behaviors		(Day	et	al.,	2015;	Simons	et	al.,	2016)	.		 The	extant	literature	suggests	that	a	similar	impaired	cognitive	processing	framework	may	apply	to	a	number	of	psychoactive	substances	beyond	alcohol,	yet	mechanisms	of	the	relationships	between	drug	use	and	sexual	risk	taking	have	been	infrequently	studied	outside	of	the	context	of	alcohol	use		(Broyd,	van	Hell,	Beale,	Yucel,	&	Solowij,	2016;	Vosburgh	et	al.,	2012)	.	Although	variation	across	drug	types	is	expected,	event-level	research	has	nevertheless	supported	links	between	acute	use	of	other	drugs	and	sexual	risk	taking.	For	instance,	use	of	methamphetamine	at	the	time	of	sex	is	strongly	associated	with	increased	sexual	risk	taking	in	MSM		(Mansergh	et	al.,	2006)	.	A	few	studies	examining	club	drugs	such	as	ecstasy/MDMA,	ketamine,	and	GHB	have	also	shown	relationships	with	increased	sexual	risk	in	bivariate,	yet	not	in	multivariate	analyses		(Vosburgh	et	al.,	2012)	.	By	contrast,	evidence	regarding	substances	such	as	nitrite	inhalants	(i.e.,	“poppers”)	and	erectile	dysfunction	drugs	has	demonstrated	mixed	or	weak	associations	with	sexual	risk	taking—likely	due	to	differing	or	negligible	effects	on	cognitive	processing		(Vosburgh	et	al.,	2012)	.	Overall,	however,	studies	regarding	event-level	associations	
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between	specific	classes	of	psychoactive	drug	use	and	sexual	risk	behavior	remain	lacking.	
Psychological	effects	of	substance	use	on	sexual	risk	behavior		 In	addition	to	the	acute	physiological	effects	substance	use	on	sexual	risk	behavior,	learned	expectancies	concerning	alcohol	and	other	drug	use	have	been	found	to	play	important	roles	in	shaping	sexual	behavior	while	under	the	influence			(Crowe	&	George,	1989;	Kalichman,	Simbayi,	Cain,	&	Jooste,	2007;	McKirnan,	Vanable,	Ostrow,	&	Hope,	2001;	Wells,	Golub,	&	Parsons,	2011)	.	For	PLWH	who	encounter	high	levels	of	stress	related	to	their	stigmatized	HIV	diagnosis,	substance	use	may	serve	as	a	means	of	coping	with	undesirable	thoughts	and	emotions	concerning	their	stigmatized	identity		(Martin,	Pryce,	&	Leeper,	2005;	Wardell,	Shuper,	Rourke,	&	Hendershot,	2018;	Wells	et	al.,	2011)	.	Commonly	held	expectancies	concerning	the	anxiety-reducing	effects	of	alcohol	and	other	drugs	have	been	shown	to	contribute	to	the	likelihood	and	frequency	of	substance	use	behavior	(Young	et	al.,	1990;	Boys	et	al.,	2001;	Parks	&	Kennedy,	2004)		(Parks	&	Kennedy,	2004;	Young,	OEI,	&	Knight,	1990)	.	Thus,	substance	use	may	be	conceptualized	as	a	form	of	disengagement	coping;	a	style	of	coping	characterized	by	orientation	away	from	stress,	as	opposed	to	attempting	to	influence	or	change	the	conditions	of	a	stressor		(Carver,	Scheier,	&	Weintraub,	1989;	Compas,	Connor-Smith,	Saltzman,	Thomsen,	&	Wadsworth,	2001;	Park	&	Iacocca,	2014;	Yi,	Sandfort,	&	Shidlo,	2010)	.	Such	disengagement	tactics	may	serve	as	a	coping	strategy	both	for	PLWH	and	for	individuals	at	risk	of	acquiring	HIV,	such	as	sexually	active	MSM.	In	people	
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who	believe	they	are	at	risk	of	acquiring	HIV,	substance	use	has	been	hypothesized	to	serve	as	a	means	of	“cognitive	escape”	from	the	perceived	threat	of	HIV	(McKirnan,	Ostrow,	&	Hope,	1996;	Wells	et	al.,	2011)	.	Paradoxically,	risky	sexual	behavior	itself	has	also	been	suggested	to	serve	as	a	form	of	disengagement	coping	to	reduce	the	anxiety	elicited	by	HIV	transmission	threat,	frequently	in	conjunction	with	substance	use		(Folkman,	Chesney,	Pollack,	&	Phillips,	1992;	Martin	et	al.,	2005)	.	In	PLWH,	substance	use	may	serve	to	facilitate	disengagement	from	a	distinct	set	of	threats.	PLWH	may	use	substances	to	disengage	from	stress	associated	with	the	perceived	risk	of	being	personally	responsible	for	transmitting	HIV	to	sexual	partners.	PLWH	may	also	use	substance	to	cope	with	the	perceived	risk	of	negative	partner	reactions	to	disclosure	of	HIV-positive	status,	with	potential	consequences	including	partner	rejection,	secondary	disclosure	of	one’s	HIV-positive	status,	and	intimate	partner	violence		(Brown	et	al.,	2016;	Serovich	&	Mosack,	2003)	.		
Substance	Use	and	HIV	Status	Disclosure	The	decision	of	whether	or	not	to	disclose	one’s	HIV-positive	status	to	a	sexual	partner	is	a	complex	social	behavior	that	depends	on	both	personal	factors	(e.g.,	disclosure	self-efficacy)	and	situational	factors	surrounding	the	sexual	event			(Bird	&	Voisin,	2011;	Kalichman	&	Nachimson,	1999;	Kalichman,	Kalichman,	Cherry,	&	Grebler,	2016)	.	While	a	number	of	situational	factors	related	to	HIV	partner	disclosure	have	been	examined	(e.g.,	meeting	venue;	sexual	partner	characteristics),	
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the	role	of	substance	use	in	HIV	disclosure	decision-making	is	not	well	understood		(Elwood,	Greene,	&	Carter,	2003;	Jones-Webb	et	al.,	2013;	Rutledge,	2007)	.	As	previously	discussed,	acute	drug	intoxication	has	been	hypothesized	to	decrease	attention	to	non-immediate	social	or	health-related	consequences	of	behavior		(Cusick,	1999;	Simons	et	al.,	2016;	Steele	&	Josephs,	1990)	.	Moreover,	given	widely	shared	beliefs	that	substance	use	impairs	decision	making,	substance	use	has	also	been	hypothesized	to	serve	as	a	social	“excuse”	for	nondisclosure,	enabling	denial	of	personal	agency	during	sexual	encounters	due	to	a	presumed	decreased	in	awareness	and	judgment		(Crowe	&	George,	1989;	Cusick,	1999;	MacAndrew	&	Edgerton,	1969)	.	A	recent	study	found	that	men	living	with	HIV	who	had	engaged	in	nondisclosed	condomless	sex	with	a	non-HIV-positive	partner	in	the	past	month	were	more	likely	to	report	having	used	drugs	or	alcohol	before	sex		(Kalichman	et	al.,	2016)	.	Qualitative	research,	by	contrast,	has	suggested	a	social	lubricant	effect	of	substance	use,	reporting	instances	in	which	substance	use	before	sex	has	been	reported	to	facilitate	disclosure,	with	some	individuals	“blurting	out”	their	HIV	status	while	“high”		(Cusick,	1999)	.	Yet	analyses	that	do	not	distinguish	between-person	differences	in	behavior	from	within-person	relationships	between	behaviors	are	vulnerable	to	confounding.	
The	Present	Study	To	date,	little	research	has	examined	the	role	of	substance	use	within	the	context	of	sexual	partner	HIV	disclosure.	The	few	existing	studies	have	examined	only	between-person	differences	in	substance	use	behavior,	and	therefore	provide	limited	insight	into	the	event-level	relationship	between	acute	substance	use	
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intoxication	and	disclosure.	The	present	study	uses	a	multi-level	modeling	approach	to	isolate	and	examine	the	event-level	correlates	of	HIV	disclosure	across	a	number	of	sexual	events	within	a	sample	of	PLWH.	Implications	of	event-level	substance	use	and	HIV	serostatus	disclosure	for	condom	use	behavior	are	also	examined.	The	present	study	observes	PLWH’s	reported	sexual	behavior	within	a	one-month	daily	prospective	observational	study.	Sexual	events	of	interest	were	those	in	which	participants	reported	anal	or	vaginal	sex	with	first-time	sexual	partners	whose	HIV	serostatus	was	HIV-negative	or	unknown.	The	study	examined	sexual	events	with	new	sexual	partners,	rather	than	longer-term	primary	partners,	due	to	the	especially	risky	nature	of	such	encounters;	PLWH	tend	to	engage	in	greater	sexual	risk	behavior	with	non-primary	sexual	partners,	with	whom	they	may	feel	less	comfort,	agency,	and	responsibility	disclose	their	stigmatized	identity	or	negotiate	condom	use	(Bird	et	al.,	2017;	Cusick,	1999;	Kalichman	&	Nachimson,	1999)	.	Moreover,	prior	event-level	research	has	found	that	alcohol	use	is	related	to	a	higher	likelihood	of	condom-unprotected	sex	with	non-primary	partners	but	not	with	primary	partners		(Vanable	et	al.,	2004)	.	Thus,	an	understanding	of	HIV	risk	behavior	in	the	context	of	first-time	sexual	encounters	is	of	particular	importance	for	prevention	efforts.	While	some	qualitative	reports	suggest	that	disinhibiting	effects	of	substance	use	may	facilitate	HIV	partner	disclosure,	both	executive	impairment	theories	(e.g.,	alcohol	myopia	theory)	and	substance	use	expectancy	theories	(e.g.,	disengagement	coping)	suggest	that	substance	use	may	reduce	the	likelihood	of	PLWH	disclosing	their	HIV	status	prior	to	sex		(Steele	&	Josephs,	1990;	Wells	et	al.,	2011)	.	
SUBSTANCE	USE,	HIV	DISCLOSURE,	&	CONDOM	USE		
	 13	
Sociocognitive	theories	such	as	the	Theory	of	Planned	Behavior	and	the	Information-Motivation-Behavioral	skills	(IMB)	model	further	suggest	that	this	decreased	information	concerning	one’s	HIV	transmission	risk	is	likely	to	reduce	the	likelihood	of	engaging	in	risk	reduction	behavior	such	as	condom	use		(Ajzen,	2002;	Fisher	&	Fisher,	1992)	.	Thus,	we	hypothesized	that	decreased	likelihood	of	disclosure	may	be	one	mechanism	by	which	substance	use	confers	increased	risk	of	HIV	transmission.	Multilevel	mediation	was	conducted	to	examine	the	relationships	between	substance	use,	HIV	partner	disclosure,	and	condom	use	as	it	varies	at	the	average,	between-person	level	and	at	the	daily	event	level	(Figure	1).	We	proposed	first	to	test	a	main	effect	of	event-level	substance	use	on	condom	use.	We	then	chose	to	examine	HIV	serostatus	disclosure	as	a	mediator	of	the	relationship	between	substance	use	and	condom	use.		
Specific	hypotheses	
H1:	We	hypothesize	that	substance	use	at	the	time	of	sex	use	will	be	associated	with	a	decreased	likelihood	of	condom	use	with	first-time	sexual	partners	whose	serostatus	is	HIV-negative	or	unknown.	
H2:	We	hypothesize	that	substance	use	at	the	time	of	sex	will	be	associated	with	decreased	likelihood	of	HIV	serostatus	disclosure	to	first-time	sexual	partners	whose	serostatus	is	HIV-negative	or	unknown.		
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H3:	We	further	hypothesize	that	nondisclosure	of	HIV	serostatus	will	be	associated	with	a	lower	likelihood	of	condom	use	during	sex	with	first-time	sexual	partners	whose	serostatus	is	HIV-negative	or	unknown.	
H4:	We	hypothesize	that	nondisclosure	of	HIV	serostatus	will	mediate	the	event-level	relationship	between	substance	use	and	condom	use.
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METHOD	
Participants	Men	and	women	age	18	or	older	were	recruited	from	community	services	and	infectious	disease	clinics	in	Atlanta,	Georgia	over	a	12-month	period	between	2013	and	2014.	Eligible	participants	had	documentation	of	being	HIV-positive.	From	this	sample,	this	study	examined	a	subsample	of	men	and	women	who	reported	anal	or	vaginal	intercourse	with	one	or	more	first-time	sexual	partners	whose	status	was	HIV-	or	unknown.	Atlanta,	Georgia	has	an	annual	HIV	incidence	of	30.3	per	100,000,	higher	than	the	mean	rate	of	19.6	new	infections	per	100,000	across	major	US	cities.	Georgia	state	law	prohibits	persons	with	HIV	from	engaging	in	sexual	intercourse	without	informing	their	sexual	partner	of	their	HIV-positive	status.	Violation	of	this	law	carries	a	felony	penalty	punishable	by	imprisonment	of	up	to	10	years	[Ga.	Code	Ann.	x	16-5-60(c)].	Awareness	of	this	law	among	participants	was	not	assessed.	
Procedures	Targeted	community	sampling	was	used	to	recruit	participants,	including	both	venue	recruitment	and	snowball	sampling	methods.	Study	brochures	were	placed	in	waiting	rooms	of	HIV	service	providers	and	infectious	disease	clinics	throughout	metropolitan	Atlanta.	Over	60%	of	participants	were	recruited	from	a	major	HIV	clinic	and	outpatient	treatment	center;	the	remainder	was	recruited	from	a	range	of	private	and	public	health	service	providers.	
SUBSTANCE	USE,	HIV	DISCLOSURE,	&	CONDOM	USE		
	 16	
	 Participants	were	provided	informed	consent	at	the	initial	office	study	assessment	before	reporting	demographic	and	health	information	via	audio-computer	assisted	self-interview	(ACASI).	Such	computer	interviews	have	been	shown	to	increase	reporting	of	socially	sensitive	behaviors	such	as	drug	use	and	sexual	behavior		(Gribble	et	al.,	2000;	Morrison-Beedy,	Carey,	&	Tu,	2006)	.	Participants	also	provided	urine	samples	for	drug	toxicity	screening.	Over	the	following	month,	participants	reported	their	sexual	behavior	prospectively	via	daily	text-message	surveys.	Past	day	sexual	behavior	surveys	were	completed	for	28	consecutive	days	on	study-provided	cell	phones.	Antiretroviral	medication	adherence	was	assessed	by	means	of	unannounced	pill	counts	(Kalichman	et	al.,	2007).	Participants	were	provided	$145	for	completing	all	study	assessments.	All	study	procedures	were	approved	by	the	university	Institutional	Review	Board.	Study	participants	were	protected	by	a	Federal	certificate	of	confidentiality.	
Measures	Time-invariant	measures		
Computer-assisted	self-interviews	for	demographic	and	health	information	Using	ACASI,	participants	reported	on	their	age,	gender,	years	of	education,	employment	status,	race/ethnicity,	and	the	year	they	first	tested	HIV-positive.	Participants	indicated	whether	they	were	currently	on	antiretroviral	therapy	(ART),	and	noted	whether	they	were	aware	of	their	most	recent	viral	load	test	results.	Participants	reported	on	their	global	alcohol	use	using	the	10-item	Alcohol	Use	Disorders	Identification	Test	(AUDIT)		(Saunders,	Aasland,	Babor,	De	la	Fuente,	
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Juan	R,	&	Grant,	1993)	.	The	AUDIT	asks	participants	to	denote	their	alcohol	use	quantity	and	frequency	in	the	past	month,	in	addition	to	other	indicators	of	problematic	alcohol	use.		 The	10-item	version	of	the	Drug	Abuse	Screening	Test	(DAST-10)	was	used	to	assess	participants’	global	drug	use	behavior		(Skinner,	1982)	.	The	measure	asked	participants	to	respond	“Yes”	or	“No”	to	10	questions	regarding	the	participant’s	non-alcohol	drug	abuse	behavior	during	the	past	3	months.	The	10-item	version	of	the	DAST	has	demonstrated	acceptable	internal	consistency	(Cronbach's	alpha	>	.85)	and	test–retest	reliability	(r	>	.70)		(Cocco	&	Carey,	1998)	.		 Participants	were	also	asked	to	report	on	their	current	depression	symptoms	using	the	Center	for	Epidemiological	Studies	Depression	questionnaire	(CES-D)		(Radloff,	1977)	.	The	CES-D	is	a	20-item	measure	that	assesses	the	presence	and	severity	of	depressive	symptoms	during	the	past	week.	The	CES-D	has	been	shown	to	be	reliable	in	previous	research	(alpha	>	.85)		(Hann,	Winter,	&	Jacobsen,	1999)	.	
Drug	use	screening	To	assess	for	illicit	drug	use,	an	FDA-approved	multipanel	urine	dip-test	was	administered.	This	test	was	used	to	screen	for	12	drugs	or	their	metabolites,	including	methamphetamine,	cocaine,	and	THC.	The	test	is	reliable	and	valid	for	initial	detection	of	drug	use.	A	positive	result	for	a	given	drug	indicated	current	use	(Reditest-12;	Redwood	Toxicology	Labs).	Event-level	measures	
Text	message-reported	daily	behavior	
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At	the	study’s	initial	office	assessment,	each	participant	was	provided	with	cell	phone	and	received	instruction	on	how	to	use	the	phone’s	text	messaging	functions.	Over	the	subsequent	28	days,	participants	received	a	prompt	by	text	message	to	report	on	their	past-day	sexual	behavior.	Daily	text	message	reporting	methods	have	been	shown	to	provide	reliable	assessment	of	socially	sensitive	behaviors		(Bernhardt	et	al.,	2009;	McAuliffe,	DiFranceisco,	&	Reed,	2010)	.	Participants	were	asked	to	report	whether	or	not	they	had	sex	the	previous	day;	if	so,	participants	were	prompted	to	specify	whether	they	engaged	in	anal	or	vaginal	sex,	whether	or	not	they	used	a	condom,	the	gender	of	their	partner,	whether	or	not	their	partner	was	aware	of	the	participant’s	HIV-positive	status	(Told	Partner/	Didn’t	tell	but	assumed	partner	knew/Partner	didn’t	know),	and	whether	the	participant	was	aware	of	their	partner’s	HIV	status	(Told	HIV+/Assume	HIV+/Told	HIV-/Assume	HIV-/Don’t	Know).	Participants	also	reported	whether	substances	were	being	used	at	the	time	of	sex	(“I	used”/“My	partner	used”/“Both	Used”/	“Neither	used”).	All	responses	were	coded	dichotomously.	Only	explicit	verbal	confirmation	regarding	HIV	status	was	considered	to	be	HIV	disclosure	(i.e.,	responses	of	“Told	partner	HIV+	status”	were	considered	disclosure,	whereas	responses	of	either	“Didn’t	tell	but	assumed	partner	knew”	and	“Partner	didn’t	know”	were	both	coded	as	nondisclosure).	Partner	HIV	status	was	also	coded	dichotomously;	participants	who	responded	that	their	partners	“Told	that	they	were	HIV+”	were	coded	as	HIV+,	whereas	all	other	responses,	including	“Assume	HIV+,”	were	coded	as	“HIV-	or	unknown.”	For	primary	analyses,	event-level	substance	use	was	defined	as	either	“I	used,”	“My	partner	used,”	or	“Both	used,”	whereas	“Neither	
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used”	was	defined	as	no	substance	use.	A	separate	variable	was	created	to	examine	participant-specific	substance	use,	in	which	substance	use	was	defined	as	“I	used”	or	“Both	used”,	and	no	substance	use	was	defined	as	“Partner	used”	or	“Neither	used.”	A	third	substance	use	variable	was	created	to	examine	partner-specific	substance	use;	for	this	variable,	substance	use	was	defined	as	“Partner	used”	and	“Both	used,”	whereas	no	substance	use	was	defined	as	“I	used”	or	“Neither	used.”	
Data	Analytic	Plan	A	multilevel	modeling	approach	was	employed	to	account	for	the	nested	structure	of	the	data	(i.e.,	daily	sexual	events	within	participants).	Data	at	level	1	were	characteristics	of	the	daily	sexual	event,	such	as	whether	substances	were	used,	whether	a	condom	was	used,	and	whether	the	participant	disclosed	their	HIV	serostatus	to	their	partner.	Data	at	level	2	were	(time-invariant)	participant	characteristics,	such	as	participant	gender,	age,	and	global	drug	(DAST)	and	alcohol	use	behavior	(AUDIT),	self-reported	at	study	entry.		 For	our	primary	analysis,	we	tested	a	two-level	random	effects	mediation	model	of	the	within-person	relations	between	event-level	(i.e.,	at	the	time	of	sex)	substance	use,	disclosure,	and	condom	use	(Figure	1).	These	models	utilized	maximum	likelihood	estimation	with	robust	standard	errors	to	account	for	the	dichotomous	nature	of	the	dependent	variables.	The	results	of	this	within-person	model	are	presented	in	Table	3.	Following	a	test	of	the	indirect	effect,	we	examined	the	proposed	mediation	paths	independently	to	observe	potential	moderating	effects.	
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We	also	tested	a	series	of	models	to	examine	the	effects	of	between-person	differences	in	overall	substance	use	behavior.	These	models	examine	the	likelihood	of	disclosure	and	condom	use	given	individual	differences	in	the	following	measures:	A)	recent	alcohol	use	behavior	(AUDIT),	and	B)	recent	drug	use	behavior	(DAST),	and	C)	proportion	of	sexual	events	in	which	participants	reported	using	substances	(Tables	4A-C).	We	also	conducted	sensitivity	analyses	to	compare	the	effects	of	different	types	of	event-level	substance	use	(e.g.,	PLWH	used	substances	vs.	both	partners	used	vs.	PLWH’s	partner	used)	(Tables	5A-C).	We	further	examined	moderating	effects	of	participant	and	partner	gender.	Within-person	effects	(i.e.,	characteristics	of	the	sexual	event)	were	coded	dichotomously.	Between-person	variables	based	on	event-level	responses	(e.g.,	individual	patterns	of	substance	use,	disclosure,	and	condom	use	during	sexual	events)	were	calculated	as	proportions.	For	example,	the	between-person	term	for	a	participant	who	reported	condom	use	on	50%	of	all	reported	sexual	events	was	calculated	as	0.5.	Between-person	effects	based	on	ACASI	responses	(i.e.,	participant	characteristics	and	patterns	of	behavior)	were	analyzed	as	continuous	(e.g.,	age,	AUDIT	score,	number	of	illicit	substances	for	which	participant	screened	positive	at	baseline)	or	categorical	(e.g.,	gender)	variables.	Results	for	both	within-person	and	between-person	effects	were	reported	as	unstandardized	betas	(β)	along	with	95%	confidence	intervals	(95%	CIs).	Within-person	effects	were	also	reported	as	odds	ratios	(ORs)	for	ease	of	interpretation.	
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To	examine	the	degree	to	which	observations	were	non-independent	across	clusters,	intra-class	correlation	coefficients	(ICCs)	were	approximated,	as	the	categorical	nature	of	the	data	prevented	ICC	calculation.	Intraclass	correlation	was	therefore	approximated	using	two	methods	to	determine	the	proportion	of	variance	accounted	for	at	level	1	(within-participant	variance)	and	level	2	(between-participant	variance).	ICCs	were	approximated	first	by	testing	the	unconditional	(empty)	model	with	a	linear	outcome	distribution	and	again	by	testing	the	model	with	a	logistic	outcome	distribution		(McCoach,	2017)	.	The	resulting	two	figures	provide	an	approximate	range	of	the	proportion	of	variance	in	the	dependent	variable	accounted	for	at	level	2.	Multilevel	statistical	analyses	were	conducted	in	MPlus	version	8		(Muthén,	L.K.	and	Muthén,	B.O.,	2012)	.	Time-invariant	data	collected	at	study	entry	were	largely	complete	(less	than	3.2%	missing	for	all	variables	of	interest).	Missing	data	were	considered	to	be	missing	completely	at	random	(MCAR).	Therefore,	full	information	maximum	likelihood	imputation	was	utilized	to	account	for	missing	data		(Little	&	Rubin,	2014)	.	Model	fit	was	assessed	using	the	Akaike	Information	Criterion	(AIC)	and	Bayesian	Information	Criterion	(BIC)	fit	indices		(Vrieze,	2012)	.	Demographic	statistics	were	analyzed	in	SPSS	version	23		(IBM	Corp,	2015)	.	Intraclass	correlation	coefficients	were	estimated	using	Hierarchical	Linear	Modeling	Version	7		(Raudenbush,	Bryk,	&	Congdon,	2017)	.	Participant	demographic	data	were	reported	as	percentages	and	as	means	(M)	with	standard	deviations	(SD).	Event-level	sexual	behavior	characteristics	were	reported	as	percentages.
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RESULTS	
Demographic	Characteristics	of	the	Sample	From	a	larger	sample	of	760	men	and	280	women	living	with	HIV,	251	participants	reported	having	had	anal	or	vaginal	sex	with	at	least	one	first-time	sexual	partner	whose	HIV	serostatus	was	negative	or	unknown		(Kalichman	et	al.,	2016)	.	Participant	characteristics	are	described	in	Table	1.	The	mean	age	of	the	sample	was	42	years,	and	participants	were	predominately	male	(84.9%),	Black/African	American	(91.6%),	and	lower	income	(62.9%	reported	annual	income	less	than	$10,000).	
Sexual	event	characteristics	Characteristics	of	sexual	events	are	described	in	Table	2.	During	the	28-day	study	period,	participants	reported	a	total	of	529	sexual	events	with	first-time	sexual	partners	whose	HIV	status	was	negative	or	unknown	(M=2.11	per	participant).	Participants	reported	having	between	one	and	twelve	such	partners	during	the	study	period,	with	120	participants	(47.8%)	reporting	two	or	more	such	partners.	The	majority	of	sexual	events	(348	events;	65.7%)	occurred	between	two	men.	Male	participants	(N=213)	reported	462	sexual	events	in	total	(M=2.17	per	participant);	and	female	participants	(N=38)	reported	67	sexual	events	in	total	(M=1.76	per	participant).	Participants	reported	using	a	condom	during	half	(49.5%)	of	all	sexual	events	and	using	substances	during	36.5%	of	all	sexual	events.	Between	both	participants	
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and	their	sexual	partners,	substance	use	was	reported	during	46.7%	of	events.	Participants	disclosed	their	HIV-positive	serostatus	to	a	third	(32.1%)	of	their	first-time,	non-HIV-positive	sexual	partners.	A	non-significant	trend	suggested	that	participants	who	reported	more	first-time	non-HIV-positive	sexual	partners	were	less	likely	to	disclose	their	HIV	serostatus	during	a	given	sexual	event,	despite	similar	patterns	of	event-level	substance	use	(β	=	-0.028,	p=0.067).	Among	participants	who	reported	two	or	more	first-time	non-HIV-positive	partners,	nearly	half	reported	inconsistent	substance	use	(40%)	and	condom	use	(40%)	across	events.	Yet	the	majority	(72.5%)	reported	a	consistent	pattern	of	serostatus	disclosure	or	nondisclosure	across	sexual	events.	Thus,	within-person	variance	in	disclosure	across	events	was	only	observed	within	in	a	small	subset	of	participants	(N=33);	these	inconsistent	disclosers	accounted	for	only	a	small	proportion	of	the	total	sample	(13.1%).	This	small	proportion	of	variance	at	the	event	level	was	corroborated	by	estimates	of	intra-class	correlation.	Estimated	ICCs	suggested	that	approximately	49%	to	58%	of	variance	in	HIV	serostatus	disclosure	was	accounted	for	at	level	2	(person-level	factors).	For	condom	use,	approximately	40%	to	46%	of	variance	was	estimated	to	be	attributable	to	between-person	factors.		
Multilevel	Mediation	Models		 To	examine	the	relations	between	substance	use,	HIV	serostatus	disclosure,	and	condom	use	in	a	sample	of	PLWH	and	their	first-time	non-HIV-positive	partners,	we	tested	a	series	of	two-level	random	intercept	models.	
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Substance	Use	and	Condom	Use	(Direct	effect)	As	part	of	our	primary	within-person	model,	the	event-level	association	between	substance	use	and	condom	use	was	tested	(Table	3).	This	two-level	random	intercept	model	controlled	for	participant	characteristics	including	age	and	gender	as	well	as	the	effect	of	sexual	partner	gender.	Contrary	to	our	hypothesis,	results	demonstrated	no	event-level	relationship	between	substance	use	and	condom	use,	suggesting	that	substance	use	at	the	time	of	sex	was	not	associated	with	likelihood	of	condomless	sex	(OR	=	1.18,	β	=	0.16,	95%	CI	[-0.50,	0.82],	p=0.630).	Despite	the	absence	of	a	statistically	significant	direct	effect	of	event-level	substance	use	on	condom	use	behavior,	we	nevertheless	sought	to	examine	the	potential	mediating	role	of	HIV	serostatus	disclosure	on	the	hypothesized	substance	use	and	condom	use	relationship.	Where	the	mediator	is	hypothesized	to	act	as	a	suppressor	variable	for	the	relationship	between	the	independent	and	dependent	variables,	the	direct	effect	need	not	be	statistically	significant	to	test	for	mediation	effects		(MacKinnon,	Fairchild,	&	Fritz,	2007)	.		Since	we	expected	that	disclosure	would	suppress	the	hypothesized	negative	relationship	between	substance	use	and	condom	use,	inconsistent	mediation	was	conducted		(Cusick,	1999;	Kalichman	et	al.,	2016)	.	
Between-Person	Models	We	also	examined	the	relations	between	individuals’	overall	substance	use	behavior	and	their	patterns	of	disclosure	and	condom	use	using	between-person	models.	Results	showed	that	self-reported	heavier	drinkers	(measured	by	AUDIT)	
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used	condoms	less	regularly	(p=0.05)	(Table	4A).	Self-reported	heavier	drug	users	(measured	by	DAST)	also	reported	using	condoms	less	frequently,	although	the	latter	trend	did	not	meet	statistical	significance	(p=0.09)	(Table	4B).	When	drug	use	was	measured	objectively	by	number	of	different	substances	used	at	study	entry	(positive	urine	drug	screens),	number	of	drugs	used	did	not	predict	condom	use.	Participants	who	more	frequently	reported	using	substances	in	their	first-time	sexual	encounters	with	non-HIV-positive	partners	were	no	less	likely	to	use	condoms	on	average	(Table	4C).	
Substance	Use	and	HIV	Disclosure	(Path	A)	To	examine	whether	HIV	serostatus	disclosure	mediates	the	relation	between	substance	use	and	condom	use,	we	first	examined	the	relation	between	event-level	substance	use	and	event-level	HIV	serostatus	disclosure	(Table	3).	In	support	of	our	hypothesis,	results	of	our	two-level	random	intercept	model	indicated	that	when	either	partner	was	using	substances	at	the	time	of	sex,	participants	were	54%	less	likely	to	disclose	their	HIV	serostatus	(OR=0.46,	β	=	-0.78,	SE	=	0.38,	95%	CI	[-1.53,	-0.05],	p	=	0.037).	Neither	AUDIT	nor	DAST	scores	were	statistically	significant	predictors	of	disclosure	after	accounting	for	the	event-level	effect	of	substance	use,	and	were	therefore	excluded	from	the	model.	Given	the	significant	effect	of	partner	gender	on	disclosure,	we	also	examined	the	relation	between	substance	use	and	disclosure	separately	in	partner	gender	subgroups.	In	events	in	which	men	had	sex	with	non-HIV-positive	men	(N=175;	348	events),	a	similar	strength	of	effect	was	found,	indicating	a	negative	relationship	between	substance	use	and	disclosure,	although	results	did	not	remain	statistically	
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significant	in	this	smaller	subgroup	(β	=	-0.67,	SE	=	0.43,	95%	CI	[-1.51,	-0.16],	p	=	0.11).	In	women	living	with	HIV	who	reported	sex	with	non-HIV-positive	men	(N=	38;	67	events),	an	especially	large	effect	of	substance	use	on	disclosure	was	observed	(β	=	-1.37,	SE	=	0.99,	95%	CI	[-3.30,	0.57],	p	=	0.16).	Although	this	effect	did	not	remain	statistically	significant	in	this	smaller	subgroup,	results	suggested	that	when	substances	were	used	at	the	time	of	sex,	women	were	74%	less	likely	to	disclose	their	HIV	serostatus	than	when	neither	partner	used	substances.	Finally,	during	sexual	events	in	which	men	living	with	HIV	reported	sex	with	non-HIV-positive	women	(N=51;	100	events),	the	relationship	between	substance	use	and	disclosure	did	not	approach	statistical	significance	(β	=	-0.27,	SE	=	1.18,	95%	CI	[-2.59,	2.05],	p	=	0.82).	To	examine	the	effect	of	substance	use	specifically	in	the	HIV-positive	partners	reporting	sexual	events	(as	opposed	to	the	substance	use	of	their	sexual	partners),	we	also	examined	the	effect	on	disclosure	of	whether	participants	
themselves	were	using	substances	at	the	time	of	sex	(i.e.,	excluding	the	role	of	partner	substance	use)	(Table	5A).	In	this	sensitivity	analysis,	the	effect	of	participant’s	own	substance	use	at	the	time	of	sex	did	not	have	a	statistically	significant	relation	with	likelihood	of	disclosure.	Although	this	effect	did	not	approach	statistical	significance,	the	direction	of	effect	nevertheless	suggested	that	when	participants	used	substances	at	the	time	of	sex,	they	were	33%	less	likely	to	disclose	their	HIV	serostatus	than	when	substances	were	not	used	(OR=0.67,	β	=	-0.40,	SE	=	0.35,	95%	CI	[-1.08,	0.28],	p	=0.25).	We	also	examined	whether	events	in	which	both	partners	were	using	substances	were	associated	with	different	
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disclosure	likelihood	than	events	in	which	neither	or	only	one	partner	used	substances	(Table	5B).	No	statistically	significant	relationship	was	found.	Finally,	we	also	compared	the	likelihood	of	disclosure	when	the	first-time	non-HIV-positive	
sexual	partner	of	the	participant	used	substances	or	not	(Table	5C).	Sexual	partner	substance	use	was	not	statistically	significantly	associated	with	disclosure,	although	the	direction	of	the	non-significant	effect	suggested	that	PLWH	may	be	less	likely	to	disclose	their	serostatus	when	their	first-time	non-HIV-positive	partners	are	using	substances	(OR=0.70	β	=	-0.36,	SE	=	0.37,	95%	CI	[-1.07,	0.36],	p	=0.33).	
Between-person	models	Heavier	drinkers	and	drug	users	by	self-report	were	less	likely	to	disclose	their	HIV	status	to	sexual	partners	on	average,	although	number	of	positive	drug	screens	did	not	predict	disclosure	(Tables	4A	&	4B).	In	participants	who	more	frequently	used	substances	during	sexual	encounters,	these	participants	were	less	likely	to	disclose	their	HIV	serostatus	(Table	4C).	
HIV	Disclosure	and	Condom	Use	(Path	B)	In	our	primary	analysis,	we	also	examined	the	event-level	relation	between	HIV	serostatus	disclosure	and	condom	use	(Table	3).	Contrary	to	hypotheses,	in	participants	who	used	condoms	inconsistently	(N=48),	participants	were	no	less	likely	to	report	condom	use	during	sexual	events	in	which	they	disclosed	their	HIV	status	(OR=1.01,	β	=	0.01,	SE	=	95%	CI	[-0.68,	0.69],	p=0.99).	This	finding	stands	in	contrast	to	our	hypothesis	that	disclosure	would	increase	the	likelihood	of	condom	use.	
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We	next	examined	the	separate	within-person	and	between-person	effects	of	disclosure	on	condom	use	together	in	one	model	(Table	6).	Despite	the	counterintuitive	within-person	effect	(in	this	model,	event-level	disclosure	was	associated	with	decreased	likelihood	of	condom	use	among	inconsistent	condom	users),	the	between-person	result	indicated	that	participants	who	consistently	used	condoms	(N=106)	were	more	likely	to	have	disclosed	their	HIV	status	than	participants	who	consistently	engaged	in	condomless	sex	(N=97)	(β	=	1.67,	SE	=	0.62,	95%	CI	[0.65,	2.69],	p	<	0.01).	Thus,	the	relationship	between	disclosure	and	condom	use	appears	to	differ	between	consistent	and	inconsistent	disclosers.	Although	event-level	substance	use	was	not	associated	with	greater	condom	use	in	the	total	sample,	we	sought	to	examine	whether	substance	use	may	exert	a	different	effect	on	condom	use	behavior	in	sexual	events	in	which	disclosure	had	occurred	vs.	those	in	which	disclosure	had	not	occurred.	Our	subgroup	analyses	showed	that	in	either	case,	substance	use	at	the	time	of	sex	was	not	significantly	associated	with	condom	use	behavior	(p’s	>	0.05).	Thus,	event-level	substance	use	does	not	appear	to	account	for	condom	non-use	following	disclosure.		 To	better	understand	this	counterintuitive	finding,	we	performed	exploratory	follow-up	analyses	to	examine	participant	characteristics	associated	with	condom	non-use	during	sexual	events	in	which	HIV	disclosure	had	occurred.	We	included	all	participants	who	reported	disclosing	their	HIV	status	to	at	least	one	non-HIV-positive	sex	partner.	We	then	compared	the	characteristics	of	those	who	always	used	condoms	during	such	events	to	those	who	did	not	always	use	condoms	in	spite	of	disclosure.	Independent-sample	t-tests	were	used	for	continuous	
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variables	and	X2	analyses	for	categorical	variables.	Comparisons	were	made	at	the	person	level.	Individuals	who	reported	condomless	sex	following	disclosure	were	found	to	have	fewer	common	HIV-related	symptoms	(t(2,	90)=2.14,	p=0.035),	poorer	safe	sex	behavioral	skills	(t(2,	90)=2.31,	p=0.007),	and	better	social	support	(t(2,	89)=-2.73,	p=0.008)	than	those	who	always	reported	condom-protected	sex	following	disclosure.	Marginal	trends	suggested	that	those	who	engaged	in	condomless	sex	following	disclosure	perceived	less	HIV	transmission	risk	associated	with	condomless	sex	(t(2,	89)=1.81,	p=0.075),	and	reported	greater	drug	use	(DAST)	(t(2,	74.4)=-1.76,	p=0.083).	No	statistically	significant	differences	were	observed	for	age,	gender,	years	since	HIV	diagnosis,	AUDIT	score,	ARV	medication	adherence,	CD4	count,	HIV	viral	load,	or	beliefs	that	treatment	reduces	HIV	transmission	risk.	Those	who	engaged	in	condomless	sex	following	disclosure	were	no	more	likely	to	have	concurrent	STIs,	to	have	a	positive	drug	screen,	or	to	be	prescribed	antiretroviral	treatment.	
Tests	of	Indirect	Effects		 A	test	of	the	indirect	effect	in	our	primary	model	did	not	find	a	mediating	effect	of	disclosure	on	the	event-level	relationship	between	substance	use	and	condom	use	(β	=	-0.00,	SE	=	0.28,	95%	CI	[-0.55,	0.54],	p	=0.99)	(Table	3).	While	event-level	substance	use	was	associated	with	decreased	likelihood	of	HIV	serostatus	disclosure	(Path	A),	nondisclosure	was	not	associated	with	condom	non-use	among	inconsistent	condom	users	(Path	B).		In	our	models	of	the	between-person	effects	of	substance	use	on	condom	use	behavior	(i.e.,	models	examining	AUDIT	scores,	DAST	scores,	number	of	positive	
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drug	screens,	and	proportion	of	sexual	events	involving	substances),	we	similarly	found	no	statistically	significant	mediation	effects,	owing	to	a	lack	of	a	relationship	between	disclosure	and	condom	use	(Tables	4A-4C).	
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DISCUSSION	To	prevent	transmission	of	HIV,	an	understanding	of	the	role	of	substance	use	in	sexual	risk	behavior	is	of	critical	importance.	Results	of	our	study	indicate	that	substance	use	at	the	time	of	sex	reduces	the	likelihood	of	PLWH	informing	casual	non-HIV-positive	sexual	partners	of	their	HIV-positive	status.	Given	that	PLWH	who	engage	in	condomless	nondisclosed	sex	are	more	likely	to	demonstrate	several	indicators	of	increased	infectiousness	(i.e.,	poorer	ARV	adherence,	more	recent	STI	infections,	and	higher	HIV	viral	load),	this	finding	is	especially	consequential	for	informing	HIV	prevention	efforts	(Kalichman	et	al.,	2016)	.	The	strength	of	the	relationship	between	substance	use	and	disclosure	appeared	to	differ	substantially	depending	on	the	genders	of	PLWH	and	their	sexual	partners.	While	smaller	sample	sizes	across	these	subgroups	precludes	definitive	conclusions,	our	results	suggest	that	the	negative	relationship	between	substance	use	and	disclosure	appears	to	be	largest	among	women	living	with	HIV,	and	smallest	among	men	living	with	HIV	when	their	non-HIV-positive	partners	are	women.	These	results	are	consistent	with	prior	research	indicating	that	women—particularly	those	with	a	history	of	sexual	victimization—may	be	more	likely	to	abdicate	sexual	safety	decision-making	while	intoxicated	due	to	anticipation	of	negative	partner	reactions		(George	et	al.,	2016;	Stappenbeck	et	al.,	2016)	.	While	we	anticipated	that	HIV	disclosure	would	facilitate	taking	greater	preventative	health	precautions,	we	were	surprised	to	find	that	disclosure	was	not	associated	with	a	greater	likelihood	of	using	a	condom	among	those	who	reported	
SUBSTANCE	USE,	HIV	DISCLOSURE,	&	CONDOM	USE		
	 32	
inconsistent	condom	use.	This	unanticipated	finding	suggests	that	the	potential	risk	reduction	benefit	of	increasing	HIV	disclosure	in	casual	sexual	encounters	may	be	overestimated.	While	surprising	in	light	of	prevailing	sociocognitive	theories	of	behavior,	our	finding	adds	to	a	growing	body	of	literature	demonstrating	mixed	support	for	an	effect	of	HIV	disclosure	on	condom	use	behavior		(Simoni	&	Pantalone,	2004;	Sullivan,	2005)	.	A	number	of	factors	may	help	to	explain	the	counterintuitive	finding	that	disclosure	of	HIV	status	to	non-HIV-positive	partners	did	not	appear	to	increase	the	frequency	of	condom	use	in	casual	encounters.	Previous	qualitative	research	has	suggested	that	sexually	risky	men	and	women	with	HIV	who	perceive	themselves	to	be	responsible	for	protecting	their	partners	may	use	risk	reduction	strategies	such	as	condom	use	to	avoid	the	socially	risky	act	of	disclosing	their	HIV	status		(Bird	&	Voisin,	2011;	Cusick,	1999)	.	However,	efforts	to	avoid	disclosure	may	not	always	result	in	increased	frequency	of	condom	use.	In	contrast,	some	PLWH	have	reported	that	when	they	wish	to	conceal	their	HIV	status,	they	may	avoid	using	a	condom	out	of	fear	that	doing	so	would	betray	their	HIV-positive	status		(Cusick,	1999)	.	Another	critical	consideration	is	that	condom	use	likely	provides	an	incomplete	measure	of	sexual	risk	reduction	efforts.	It	is	therefore	possible	that	the	lack	of	a	relationship	between	disclosure	and	condom	use	may	be	attributable	to	sexual	harm	reduction	methods	not	captured	in	the	present	study		(Parsons,	Schrimshaw,	Wolitski	et	al.,	2005)	.	Risk	reduction	strategies	such	as	strategic	positioning,	serosorting,	and	withdrawal	before	ejaculation	may	be	alternative	methods	by	which	PLWH	and	their	partners	attempt	to	decrease	HIV	transmission	risk		(Cruess	et	al.,	2017;	
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Dangerfield,	Smith,	Williams,	Unger,	&	Bluthenthal,	2017;	Eaton,	Kalichman,	O'Connell,	&	Karchner,	2009;	McFarland	et	al.,	2012;	Vallabhaneni	et	al.,	2012)	.	Although	not	captured	in	the	present	study,	reliance	upon	such	alternative	risk	reduction	tactics	could	help	to	explain	high	rates	of	condomless	sex	between	serodiscordant	partners	even	following	disclosure.	Some	potential	partners	of	PLWH	may	also	abstain	from	anal	or	vaginal	sex	altogether	following	their	partner’s	HIV	disclosure,	rather	than	using	condoms.	Our	study	also	contributes	to	a	conflicting	body	of	evidence	concerning	the	acute	effects	of	substance	use	on	condom	use	decision-making.	Consistent	with	prior	literature,	our	between-person	measures	of	substance	use	suggested	that	heavier	alcohol	drinkers	were	those	most	likely	to	engage	in	condom-unprotected	sex		(Koblin	et	al.,	2006b;	Mayer	et	al.,	2014;	Scott-Sheldon	et	al.,	2013)	.	Yet	our	test	did	not	support	an	event-level	relationship	between	substance	use	and	condom	use,	suggesting	that	substance	use	at	the	time	of	sex	did	not	increase	sexual	risk-taking	after	accounting	for	these	between-person	characteristic	use	patterns.	Although	lab-based	research	has	indicated	that	acute	alcohol	intoxication	is	associated	with	increased	willingness	to	engage	in	condomless	sex,	results	from	this	sample	corroborate	previous	event-level	analyses	that	have	failed	to	find	an	immediate	relationship	between	substance	use	and	sexual	risk	behavior		(Davis	et	al.,	2009;	George	et	al.,	2009;	Gillmore	et	al.,	2002;	Reilly	&	Woo,	2001)	.	This	evidence	may	point	to	the	primacy	of	person-level	factors	such	sensation	seeking	in	explaining	the	relationship	between	substance	use	and	sexual	risk	behavior.	Alternatively,	they	
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may	indicate	a	lack	of	sensitivity	in	the	current	study’s	assessment	of	substance	use	behavior.		 In	spite	of	the	design	strengths	of	the	present	study,	several	notable	limitations	warrant	discussion.	As	is	true	of	the	majority	of	sexual	behavior	research,	our	study	was	limited	by	its	reliance	on	self-report.	With	regard	to	measurement	of	socially	sensitive	behaviors	such	as	condom	use,	HIV	disclosure,	and	substance	use,	some	underreporting	is	likely.	Previous	examinations	of	alcohol	use	self-report	have	demonstrated	limited	test-retest	reliability		(Johnson,	Pratt,	Neal,	&	Fisher,	2010)	.	Sexual	behavior	data	is	also	vulnerable	to	underreporting	bias,	with	inaccuracy	of	self-report	during	retrospective	recall	found	to	be	greatest	among	those	at	highest	transmission	risk,	such	as	those	who	report	more	casual	partners	and	those	with	lower	education	levels		(Jaccard	et	al.,	2004)	.	To	minimize	the	possibility	of	underreporting	bias,	our	study	utilized	state-of-the-art	daily	electronic	data	collection	methodology.	This	method	has	demonstrated	reliable	measurement	of	socially	sensitive	behaviors	in	previous	research,	yet	such	methods	cannot	entirely	remove	the	possibility	of	underreporting		(Bernhardt	et	al.,	2009;	McAuliffe	et	al.,	2010)	.		 A	second	limitation	of	our	study	is	the	lack	of	specific	data	characterizing	event-level	substance	use.	To	reduce	study	burden,	participants	answered	one	item	regarding	substance	use	during	each	sexual	event	(i.e.,	specifying	whether	both	the	participant	and/or	their	sexual	partner	had	used	substances).	While	this	brief	question	format	provided	participants	with	a	less	demanding	daily	burden,	greater	specificity	concerning	the	variety	of	substance(s)	used	would	have	offered	valuable	
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data	concerning	differential	substance	use	effects.	As	substances	vary	in	their	psychoactive	effects	and	associated	behavioral	expectancies,	the	present	study’s	lack	of	granularity	concerning	the	types	of	substances	used	may	have	obscured	some	relationships	between	substance	use	and	associated	sexual	behaviors.	Further,	as	prior	event-level	studies	of	alcohol	use	have	detected	relationships	between	number	of	drinks	consumed	and	daily	sexual	risk	behavior,	predictive	value	may	also	have	been	missed	by	failing	to	capture	impairment		(Barta	et	al.,	2008)	.		Finally,	our	study	was	limited	in	its	scope.	Much	event-level	research	does	not	account	for	the	potential	importance	of	contextual	factors	such	as	meeting	venue	for	HIV	transmission	risk	behavior		(Grov,	2012;	Horvath,	Bowen,	&	Williams,	2006;	Jones-Webb	et	al.,	2013)	.	While	some	research	has	indicated	that	sexual	risk	behavior	appears	to	be	more	contingent	on	personal	psychosocial	factors	than	on	meeting	venue	features,	risk	behavior	norms	nevertheless	appear	to	differ	significantly	across	venue	types	in	MSM	(Grov,	Parsons,	&	Bimbi,	2007;	Grov,	2012)	.		 Despite	these	limitations,	this	study	utilized	sensitive	and	state-of-the-art	electronic	diary	data	collection,	and	applied	a	multilevel	modeling	analytic	approach	that	provided	significant	methodological	advantages.	Analytic	methods	that	fail	to	account	for	non-independence	of	observations	when	data	is	clustered	increase	the	likelihood	of	Type	I	error		(Musca	et	al.,	2011)	.	Additionally,	attempts	to	examine	within-person	phenomena	using	between-person	measures	are	vulnerable	to	a	variety	of	potential	confounders	that	may	bias	findings		(Robinson,	1950)	.	In	contrast,	the	present	study	utilized	a	robust	and	conservative	analytic	approach	to	
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isolate	the	event-level	factors	that	influence	sexual	risk	decision-making.	In	the	present	study,	all	estimates	of	intraclass	correlation	indicated	that	a	substantial	proportion	of	variance	in	the	dependent	variables	was	accounted	for	by	level	2	factors.	These	tests	provide	another	strong	statistical	justification	for	the	necessity	of	a	multilevel	analytic	approach	rather	than	ignoring	participant	variance	in	analysis	of	specific	events.	
Future	directions		 The	present	study	highlights	the	complex	and	multifactorial	interplay	of	personal	and	situational	factors	that	influence	HIV	transmission	risk	behavior	in	PLWH.	Future	research	should	continue	to	utilize	event-level	methodology	to	better	understand	the	causal	pathways	by	which	substance	use	may	influence	sexual	risk	behavior.	Greater	specificity	in	measurement	substance	use	type	and	impairment	is	needed	to	better	understand	the	impact	of	substance	use	on	health	behavior	decision-making.		Irrespective	of	the	immediate	effects	that	substance	use	may	exert	on	sexual	health	decision-making,	substance	use	is	strongly	linked	to	HIV	transmission	risk	through	a	number	of	indirect	pathways.	Problematic	drug	and	alcohol	use	has	been	consistently	linked	with	lack	of	successful	engagement	in	HIV	testing	and	care	among	PLWH,	which	increases	the	risk	of	transmission	of	HIV	due	to	unsuppressed	HIV	viral	load,	in	addition	to	increasing	HIV	disease	severity		(Cohen,	1998;	Lucas,	Cheever,	Chaisson,	&	Moore,	2001;	Parsons,	Kowalczyk,	Botsko,	Tomassilli,	&	Golub,	2013;	Quinn	et	al.,	2000;	Vagenas	et	al.,	2015;	Williams	et	al.,	2018)	.	Personal	factors	such	as	sexual	compulsivity,	sensation	seeking,	and	belonging	to	high-risk	
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sexual	networks	may	also	account	for	much	of	the	association	between	substance	use	and	HIV	transmission	risk		(Day	et	al.,	2015;	Hernandez-Romieu	et	al.,	2015;	Kalichman,	Cain,	Zweben,	&	Swain,	2003;	Newcomb,	Clerkin,	&	Mustanski,	2011;	Norris	et	al.,	2009)	.	Thus,	future	studies	should	strive	to	measure	and	examine	relevant	risk-related	beliefs	as	well	as	personality	and	demographic	factors	that	may	contribute	to	increased	HIV	transmission	risk	behavior	in	substance-using	PLWH	and	their	partners.		 In	light	of	the	disproportionately	high	risk	of	HIV	transmission	among	people	who	use	substances,	interventions	that	address	sexual	risk	reduction	in	this	population	must	address	the	complex	etiology	of	HIV	risk	behaviors	in	this	population.	Successful	behavioral	change	interventions	should	target	multiple	behaviors	concurrently		(Coates,	Richter,	&	Caceres,	2008)	.	Promotion	of	partner	HIV	disclosure	may	be	a	valuable	adjunct	to	sexual	risk	reduction	strategies,	yet	alone	may	be	insufficient	for	reliably	improving	sexual	health	behavior.	Addressing	substance	use	disorders,	barriers	to	medication	adherence,	concurrent	STIs,	trauma,	stigma,	and	mental	health	concerns,	are	all	critical	supplements	for	successful	behavioral	prevention	interventions	in	PLWH		(Burnham	et	al.,	2016;	Kalichman	et	al.,	2016;	Stappenbeck	et	al.,	2016;	Williams	et	al.,	2018)	.	For	instance,	methadone	maintenance	treatment	for	opioid	drug	using	PLWH	may	help	to	reduce	sexual	risk	behavior	by	reducing	reliance	on	transactional	sex		(Karki,	Shrestha,	Huedo-Medina,	&	Copenhaver,	2016)	.	Promotion	of	sexual	risk	reduction	in	the	context	of	more	recreational	forms	of	alcohol	or	other	drug	use	is	also	warranted.	
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	 Given	the	multiple	means	by	which	people	may	attempt	to	reduce	sexual	transmission	risk,	future	research	should	examine	use	of	alternative	risk	reduction	strategies	beyond	condom	use.	Understanding	use	of	perceived	sexual	harm	reduction	practices	such	as	strategic	sexual	positioning	may	shed	greater	light	on	the	decision-making	frameworks	utilized	by	PLWH	and	their	partners		(Parsons	et	al.,	2005)	.	Similarly,	greater	understanding	of	evolving	HIV	risk	perceptions	and	beliefs	(e.g.,	treatment-as-prevention	beliefs)	may	help	to	understand	sexual	risk	behaviors		(Kalichman	et	al.,	2017)	.	Considering	the	fundamentally	interpersonal	nature	of	sexual	risk	behaviors,	dyadic	analysis	may	also	help	to	understand	the	interplay	of	beliefs,	behaviors,	risk	perceptions,	skills,	and	anticipated	partner	reactions	involved	in	negotiating	sexual	health	decisions	between	partners.	Researchers	should	also	examine	the	role	of	emerging	pharmaceutical	alternatives	such	as	Pre-Exposure	Prophylaxis	(PrEP)	in	sexual	health	decision-making.	Such	biomedical	alternatives	carry	tremendous	potential	to	reduce	the	consequences	associated	with	sexual	risk	behaviors	made	in	the	“heat	of	the	moment”	among	partners	of	PLWH.	Nevertheless,	potential	risk	compensation	behavior	such	as	condom	non-use	in	PrEP	user	should	be	scrutinized,	given	the	increased	risk	of	HIV	transmission	associated	with	concurrent	STI	infection		(Cohen,	1998;	Cohen,	2012)	.	Uptake	of	PrEP	remains	sporadic,	and	rates	of	PrEP	use	remain	particularly	low	among	those	at	greatest	risk	for	acquiring	HIV		(Eaton,	Driffin,	Bauermeister,	Smith,	&	Conway-Washington,	2015;	Mimiaga,	Closson,	Kothary,	&	Mitty,	2014)	.	Thus,	sexual	partners	of	PLWH	may	be	especially	unlikely	to	obtain	
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the	benefits	of	PrEP,	further	emphasizing	the	importance	of	effective	behavioral	prevention	interventions	in	PLWH.	
Conclusions		 This	study	is	the	first	to	apply	multilevel	modeling	methodology	to	examine	the	immediate	determinants	of	HIV	serostatus	disclosure	in	PLWH’s	first-time	sexual	encounters	with	non-HIV-positive	partners.	Our	findings	offer	an	important	contribution	to	understanding	the	role	of	substance	use	in	HIV	transmission	risk	behavior.	We	found	that	use	of	substances	at	the	time	of	sex	appears	to	be	associated	with	lower	likelihood	of	disclosing	one’s	HIV-positive	status	to	casual	sex	partners.	Yet	while	nondisclosure	of	HIV	status	was	more	frequent	when	substances	were	used	at	the	time	of	sex,	this	nondisclosure	was	not	associated	with	lower	likelihood	of	condom	use	in	those	who	used	condoms	inconsistently.	Our	study	also	contributes	to	the	mixed	literature	concerning	the	relationship	between	substance	use	and	condom	use.	We	found	that	heavier	alcohol	users	were	more	likely	to	engage	in	condomless	sex,	yet	substance	use	at	the	time	of	sex	was	not	associated	with	a	greater	likelihood	of	condomless	sex	in	inconsistent	condom	users.	Our	findings	provide	insight	regarding	the	socially	fraught	process	of	sexual	health	decision-making	in	PLWH,	and	add	nuance	regarding	the	complex	and	multiple	relations	between	substance	use	and	sexual	risk	behavior.
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TABLES	&	FIGURES	
Table	1:	Participant	Demographics		 N=	251	
Mean	(SD)/	N	(%)	Age	(Years)	 42.0	(10.1)	Gender	Male	Female		Trans	Male	Trans	Female	
	213	(84.9%)	38	(15.1%)		10	(4.0%)	8	(3.2%)	Race/Ethnicity	Black/African	American	White	Hispanic/Latino	Other	
	230	(91.6%)	14	(5.6%)	2	(0.8%)	5	(2.0%)	Household	Annual	Income	Under	$10,000	$11,000-$20,000	$21,000-$30,000	Over	$30,000	
	158	(62.9%)	57	(22.7%)	25	(10.0%)	10	(4.0%)	Healthcare	Coverage	in	past	2	years	No	coverage	past	2	years	 	179	(71.3%)	72	(28.7%)	Employment	Status	Unemployed	Working	On	disability	Student	Other	
	81	(32.3%)	48	(19.1%)	109	(43.4%)	6	(2.4%)	7	(2.8%)	Education	7th-11th	grade	12th	grade	or	GED	Some	College	Completed	College	
	43	(17.1%)	74	(29.5%)	81	(32.3%)	53	(21.1%)	Years	since	HIV	Diagnosis	 12.3	(8.3)	CES-D	(0-60)	 17.6	(12.2)	AUDIT	(0-40)	0	1-8	8+	
	74	(29.5%)	135	(53.7%)	39	(15.5%)	Drug	Abuse	Screening	Test	(DAST)	(0-10)	 1.5	(2.0)		 	
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Drug	Use	(Positive	urine	tox	screen	%)	THC	(Cannabis)	Cocaine	Benzodizepines	Opiates	Methamphetamine	Amphetamines	Oxycontin	MDMA	PCP	Barbituates	Methadone	
	70	(27.9%)	70	(27.9%)	24	(9.6%)	9	(3.6%)	9	(3.6%)	7	(2.8%)	7	(2.8%)	3	(1.2%)	2	(0.8%)	1	(0.4%)	1	(0.4%)	Number	of	first-time	non-HIV-positive	sexual	partners	in	28-day	study	period	1	2	3	4	5	or	more	
		131	(52.2%)	63	(25.1%)	22	(8.8%)	12	(4.8%)	23	(9.2%)		
Table	2:	Sexual	Event	Characteristics	(Event	N=529)		
Participant	Gender	
(PLWH)	
Man	 Woman	
Partner	Gender	
(HIV-/unknown	HIV	
status	partner)	
Man	(348	events)	 Woman	(100	events)	 Transgender	(14	events)	 Man	(67	events)	Participant	and/or	partner	used	substances		 166	(47.7%)	 46	(46.0%)	 7	(50%)	 28	(41.8%)	Participant	Used	Substances		 132	(37.9%)	 30	(30.0%)	 6	(42.9%)	 25	(37.3%)	Partner	Used	Substances		 115	(33.0%)	 28	(28.0%)	 5	(35.7%)	 12	(17.9%)	Participant	disclosed	positive	HIV	serostatus		 106	(30.5%)	 34	(34.0%)	 7	(50%)	 23	(34.3%)	Condom	Used		 151	(43.4%)		 71	(71.0%)		 9	(64.3%)		 31	(46.3%)			
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Table	3:	Within-Person	Mediation	Model		 OR	 Estimate	(95%	CI)	 SE	 t	 p	
Within-Person	Effects	 	 	 	 	 	
Disclosure	 	 	 	 	 	Either	partner	used	substances	(Path	A)	 0.46	 -0.79	(-1.53,	-0.05)	 0.38	 -2.09	 0.037	Partner	gender	 1.81	 0.59	(-0.34,	1.53)	 0.48	 1.25	 0.212		 	 	 	 	 	
Condom	Use	 	 	 	 	 	Either	partner	used	substances	(Direct	Effect)	 1.18	 0.16	(-0.50,	0.82)	 0.34	 0.48	 0.630	Participant	disclosed	HIV+	status	(Path	B)	 1.01	 0.01	(-0.68,	0.69)	 0.35	 0.01	 0.990	Partner	Gender	 4.43	 1.49	(0.56,	2.42)	 0.47	 3.14	 0.002		 	 	 	 	 	
Between-Person	Effects	 	 	 	 	 	
Disclosure	 	 	 	 	 	Participant	gender	 	 0.57	(-0.91,	2.05)	 0.76	 0.76	 0.451	Participant	age	 	 0.03	(-0.02,	0.09)	 0.03	 1.14	 0.256		 	 	 	 	 	
Condom	use	 	 	 	 	 	Participant	gender	 	 0.18	(-0.95,	1.32)	 0.58	 0.32	 0.753	Participant	age	 	 -0.03	(-0.07,	0.01)	 0.02	 -1.49	 0.137		 	 	 	 	 	
Test	of	indirect	effect	 	 	 	 	 	Path	A*Path	B	 	 -0.00	(-0.55,	0.54)	 0.28	 -0.01	 0.990		AIC:	1214.87;			BIC:	1270.39											OR:	odds	ratio;	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level.
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Table	4A:	Between-Person	Mediation	Model—Alcohol	Use	(AUDIT)		 Estimate	(95%	CI)	 SE	 t	 p	
Between-Person	Effects	 	 	 	 	
Disclosure	 	 	 	 	AUDIT	(Path	A)	 -0.01	(-0.02,	-0.00)	 0.04	 -2.59	 0.010	Participant	gender	 0.05	(-0.12,	0.21)	 0.08	 0.56	 0.576	Participant	age	 0.00	(-0.00,	0.01)	 0.00	 1.39	 0.166		 	 	 	 	
Condom	Use	 	 	 	 	AUDIT	(Direct	Effect)	 -0.07	(-0.14,	0.00)	 0.04	 -1.93	 0.054	Participant	disclosed	HIV+	status	(Path	B)	 0.65	(-0.25,	1.54)	 0.46	 1.42	 0.157	Participant	gender	 -0.32	(-1.45,	0.80)	 0.58	 -0.56	 0.573	Participant	age	 -0.02	(-0.06,	0.02)	 0.02	 -1.01	 0.311		 	 	 	 	
Test	of	indirect	effect	 	 	 	 	Path	A*Path	B	 -0.01	(-0.02,	0.00)	 0.01	 -1.21	 0.227		AIC:	1284.41;			BIC:	1339.93	OR:	odds	ratio;	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level.			
Table	4B:	Between-Person	Mediation	Model—Illicit	Drug	Use	(DAST)			 Estimate	(95%	CI)	 SE	 t	 p	
Between-Person	Effects	 	 	 	 	
Disclosure	 	 	 	 	DAST	(Path	A)	 -0.03	(-0.05,	-0.01)	 0.01	 -2.34	 0.019	Participant	gender	 0.05	(-0.12,	0.21)	 0.08	 0.56	 0.579	Participant	age	 0.01	(-0.00,	0.01)	 0.00	 1.59	 0.113		 	 	 	 	
Condom	Use	 	 	 	 	DAST	(Direct	Effect)	 -0.16	(-0.34,	0.03)	 0.09	 -1.68	 0.094	Participant	disclosed	HIV+	status	(Path	B)	 0.68	(-0.23,	1.58)	 0.46	 1.47	 0.143	Participant	gender	 -0.33	(-1.46,	0.80)	 0.58	 -0.57	 0.568	Participant	age	 -0.02	(-0.06,	0.02)	 0.02	 -0.87	 0.387		 	 	 	 	
Test	of	indirect	effect	 	 	 	 	Path	A*Path	B	 -0.02	(-0.05,	0.01)	 0.02	 -1.23	 0.221		AIC:	2020.90;			BIC:	2076.42	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level.
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Table	4C:	Between-Person	Mediation	Model—Frequency	of	Using	Substances	
at	Time	of	Sex			 Estimate	(95%	CI)	 SE	 t	 p	
Between-Person	Effects	 	 	 	 	
Disclosure	 	 	 	 	Participant	substance	use	frequency	(Path	A)	 -0.17	(-0.29,	-0.04)	 0.06	 -2.59	 0.009	Participant	gender	 0.05	(-0.11,	0.20)	 0.08	 0.61	 0.542	Participant	age	 0.00	(-0.00,	0.01)	 0.00	 1.24	 0.216		 	 	 	 	
Condom	Use	 	 	 	 	Participant	substances	use	frequency	(Direct	Effect)	 -0.28	(-1.26,	0.71)	 0.50	 -0.55	 0.580	Participant	disclosed	HIV+	status	(Path	B)	 0.71	(-0.20,	1.62)	 0.47	 1.53	 0.126	Participant	gender	 -0.24	(-1.50,	1.01)	 0.64	 -0.38	 0.706	Participant	age	 -0.02	(-0.06,	0.02)	 0.02	 -0.88	 0.376		 	 	 	 	
Test	of	indirect	effect	 	 	 	 	Path	A*Path	B	 -0.12	(-0.29,	0.06)	 0.09	 -1.34	 0.182		AIC:	3330.01				BIC:	3402.62	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level.		
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Table	5A:	Path	A	Model	Predicting	Participant	HIV	Disclosure	from	Event-
Level	Substance	Use	(Participant	using)		 OR	 Estimate	(95%	CI)	 SE	 t	 p	
Within-Person	Effects	 	 	 	 	 	Participant	used	substances	 0.67	 -0.40	(-1.08,	0.28)	 0.35	 -1.16	 0.25	Partner	gender	 1.80	 0.59	(-0.34,	1.52)	 0.47	 1.24	 0.21		 	 	 	 	 	
Between-Person	Effects	 	 	 	 	 	Participant	gender	 	 0.77	(-0.70,	2.24)	 0.75	 1.03	 0.30	Participant	age	 	 0.03	(-0.02,	0.08)	 0.03	 1.10	 0.27		AIC:	1304.41;			BIC:	1338.6	OR:	odds	ratio;	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level.		
	
Table	5B:	Path	A	Model	Predicting	Participant	HIV	Disclosure	from	Event-
Level	Substance	Use	(Both	partners	using)		 OR	 Estimate	(95%	CI)	 SE	 t	 p	
Within-Person	Effects	 	 	 	 	 	Both	used	substances	 0.96	 -0.04	(-0.97,	0.89)	 0.47	 -0.09	 0.93	Partner	gender	 1.80	 0.59	(-0.35,	1.53)	 0.48	 1.22	 0.22	
	 	 	 	 	 	
Between-Person	Effects	 	 	 	 	 	Participant	gender	 	 0.70	(-0.78,	2.18)	 0.76	 0.93	 0.35	Participant	age	 	 0.03	(-0.03,	0.08)	 0.03	 0.98	 0.32		AIC:	1110.25;			BIC:	1144.42	OR:	odds	ratio;	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level		
Table	5C:	Path	A	Model	Predicting	Participant	HIV	Disclosure	from	Event-
Level	Substance	Use	(Sexual	partner	using)		 OR	 Estimate	(95%	CI)	 SE	 t	 p	
Within-Person	Effects	 	 	 	 	 	Partner	used	substances	 0.70	 -0.36	(-1.07,	0.36)	 0.37	 -0.98	 0.33	Partner	gender	 1.77	 0.57	(-0.35,	1.50)	 0.47	 1.21	 0.23	
	 	 	 	 	 	
Between-Person	Effects	 	 	 	 	 	Participant	gender	 	 0.63	(-0.83,	2.10)	 0.75	 0.85	 0.40	Participant	age	 	 0.03	(-0.03,	0.08)	 0.03	 0.99	 0.32		AIC:	1257.92;			BIC:	1292.11	OR:	odds	ratio;	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level	
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Table	6:	Path	B	Model	Predicting	Condom	Use	from	Event-Level	HIV	Disclosure			 OR	 Estimate	(95%	CI)	 SE	 t	 p	
Within-Person	Effects	 	 	 	 	 	Participant	HIV	Disclosure	 0.39	 -0.94	(-1.62,	-0.26)	 0.41	 -2.27	 0.02	Partner	gender	 4.51	 1.51	(0.74,	2.27)	 0.47	 3.23	 0.001	
	 	 	 	 	 	
Between-Person	Effects	 	 	 	 	 	Disclosure	Frequency	 	 1.67	(0.65,	2.69)	 0.62	 2.69	 0.007	Participant	gender	 	 0.02	(-0.92,	0.96)	 0.57	 0.04	 0.97	Participant	age	 	 -0.03	(-0.07,	0.00)	 0.02	 -1.67	 0.10		AIC:	1656.42				BIC:	1703.41	OR:	odds	ratio;	95%	CI:	95%	confidence	interval.	SE:	standard	error.	
Bold	denotes	statistically	significant	effect	at	p<0.05	level				
Figure	1:	Proposed	Mediation	Model		
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APPENDIX:	MPlus	Code	for	Event-Level	Analyses	
Within-Person	Mediation	Model	(Results	Reported	in	Table	3)		INPUT	INSTRUCTIONS	TITLE:	Substance	use,	disclosure,	and	condom	use	mediation	–	Within-person	DATA:	FILE	IS	Data.csv;	VARIABLE:	NAMES	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	USEVAR	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	CATEGORICAL	ARE	disclosure	condomuse;	CLUSTER	=	id;	WITHIN	=	substanceuse	partnergender;	BETWEEN	=	participantgender	age;	Missing	are	all	(-99);	ANALYSIS:	TYPE	=	twolevel	random;	ESTIMATOR=mlr;	MODEL:	%WITHIN%	disclosure	ON	substanceuse	(awithin);	condomuse	ON	disclosure	(bwithin);	condomuse	ON	substanceuse;	condomuse	ON	partnergender;	disclosure	ON	partnergender;	%BETWEEN%	disclosure	condomuse;	disclosure	ON	participantgender;	discosure	ON	age;	condomuse	ON	participantgender;	condomuse	ON	age;	MODEL	CONSTRAINT:	NEW	(indw);	indw=awithin*bwithin;	OUTPUT:	sampstat	cinterval;		
SUBSTANCE	USE,	HIV	DISCLOSURE,	&	CONDOM	USE		
	 68	
Between-Person	Mediation	Model	(Results	Reported	in	Tables	4	A-C)	
Four	model	versions	alternately	utilized	between-person	“substanceuse”	terms	derived	
from	a)	AUDIT	score,	b)	DAST	score,	c)	proportion	of	events	using	substances,	and	d)	
number	of	positive	drug	screens	at	study	entry		INPUT	INSTRUCTIONS	TITLE:	Substance	use,	disclosure,	and	condom	use	mediation	–	Between-person	DATA:	FILE	IS	Data.csv;	VARIABLE:	NAMES	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	USEVAR	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	CATEGORICAL	ARE	condomuse;	CLUSTER	=	id;	WITHIN	=;	BETWEEN	=	substanceuse	disclosure	participantgender	age;	Missing	are	all	(-99);	ANALYSIS:	TYPE	=	twolevel	random;	ESTIMATOR=mlr;	MODEL:	%WITHIN%	%BETWEEN%	substanceuse	disclosure	condomuse	gender	age;	disclosure	ON	substanceuse	(abetween);	condomuse	ON	disclosure	(bbetween);	condomuse	ON	substanceuse;	condomuse	ON	participantgender;	condomuse	ON	age;	disclosure	ON	participantgender;	discosure	ON	age;	MODEL	CONSTRAINT:	NEW	(indb);	indv=abetween*bbetween;	OUTPUT:	sampstat	cinterval;		
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Path	A	Model	Predicting	Participant	HIV	Disclosure	from	Event-Level	
Substance	Use	(Results	Reported	in	Tables	5	A-C)		
Model	versions	A-C	alternately	utilized	independent	variable	“substanceuse”	terms	
derived	from	event	level	reporting	of	a)	Participant	Using	Substances,	b)	Both	Partners	
Using	Substances,	and	c)	Participant’s	Sexual	Partner	Using	Substances		INPUT	INSTRUCTIONS	TITLE:	Path	A:	Event-level	substance	use	and	disclosure	DATA:	FILE	IS	Data.csv;	VARIABLE:	NAMES	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	USEVAR	ARE	id	substanceuse	disclosure	partnergender	participantgender	age;	CATEGORICAL	ARE	disclosure;	CLUSTER	=	id;	WITHIN	=	substanceuse	parntergender;	BETWEEN	=	participantgender	age;	Missing	are	all	(-99);	ANALYSIS:	TYPE	=	twolevel	random;	ESTIMATOR=mlr;	MODEL:	%WITHIN%	substanceuse;	disclosure	ON	substanceuse;	disclosure	ON	partnergender;	%BETWEEN%	disclosure;	disclosure	ON	participantgender;	disclosure	ON	age;	OUTPUT:	sampstat	cinterval;		
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Path	B	Model	Predicting	Condom	Use	from	Event-Level	HIV	Disclosure—
Within-Person	and	Between-person	terms	included	(Results	Reported	in	
Table	6)		INPUT	INSTRUCTIONS	TITLE:	Path	B:	Event-level	disclosure	and	condom	use	DATA:	FILE	IS	Data.csv;	VARIABLE:	NAMES	ARE	id	condomuse	disclosure	disclosurefrequency	partnergender	participantgender	age;	USEVAR	ARE	id	condomuse	disclosure	disclosurefrequency	partnergender	participantgender	age;	CATEGORICAL	ARE	condomuse;	CLUSTER	=	id;	WITHIN	=	disclosure	parntergender;	BETWEEN	=	disclosurefrequency	participantgender	age;	Missing	are	all	(-99);	ANALYSIS:	TYPE	=	twolevel	random;	ESTIMATOR=mlr;	MODEL:	%WITHIN%	disclosure;	condomuse	ON	disclosure;	condomuse	ON	partnergender;	%BETWEEN%	condomuse;	condomuse	ON	disclosurefrequency;	condomuse	ON	participantgender;	condomuse	ON	age;	OUTPUT:	sampstat	cinterval;			
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Main	effect	subgroup	analyses:	disclosure	status	
Identical	model	run	in	subgroups	of	a)	events	in	which	HIV	disclosure	was	reported	
and	b)	events	in	which	HIV	non-disclosure	was	reported		INPUT	INSTRUCTIONS	TITLE:	Substance	use,	disclosure,	and	condom	use	mediation	–	Between-person	DATA:	FILE	IS	Data.csv;	VARIABLE:	NAMES	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	USEVAR	ARE	id	condomuse	substanceuse	disclosure	partnergender	participantgender	age;	CATEGORICAL	ARE	condomuse;	CLUSTER	=	id;	WITHIN	=	substanceuse	parntergender;	BETWEEN	=	participantgender	age;	Missing	are	all	(-99);	ANALYSIS:	TYPE	=	twolevel	random;	ESTIMATOR=mlr;	MODEL:	%WITHIN%	substanceuse;	condomuse	ON	substanceuse;	condomuse	ON	partnergender;	%BETWEEN%	substanceuse;	condomuse	ON	participantgender;	condomuse	ON	age;	OUTPUT:	sampstat	cinterval;	
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Main	effect	subgroup	analyses	by	gender	and	partner	gender	
To	examine	potential	moderating	effects	of	gender/partner	gender,	the	full	mediation	
model	reported	in	Table	3	was	applied	separately	to	participant	gender/partner	
gender	subgroups,	with	gender	and	partner	gender	terms	removed	(displayed	below).	
The	identical	model	was	run	in	a)	MSM,	b)	MSW,	and	c)	WSM	participant	subgroups.		INPUT	INSTRUCTIONS	TITLE:	Substance	use,	disclosure,	and	condom	use	mediation	–	Within-person	DATA:	FILE	IS	Data.csv;	VARIABLE:	NAMES	ARE	id	condomuse	substanceuse	disclosure	age;	USEVAR	ARE	id	condomuse	substanceuse	disclosure	age;	CATEGORICAL	ARE	disclosure	condomuse;	CLUSTER	=	id;	WITHIN	=	substanceuse;	BETWEEN	=	age;	Missing	are	all	(-99);	ANALYSIS:	TYPE	=	twolevel	random;	ESTIMATOR=mlr;	MODEL:	%WITHIN%	disclosure	ON	substanceuse	(awithin);	condomuse	ON	disclosure	(bwithin);	condomuse	ON	substanceuse;	%BETWEEN%	disclosure	condomuse;	disclosure	ON	age;	condomuse	ON	age;	MODEL	CONSTRAINT:	NEW	(indw);	indw=awithin*bwithin;	OUTPUT:	sampstat	cinterval;		
